Orthofix Medical Inc. Business Combination, Contingent Consideration, Liability, Current
Orthofix Medical Inc. (OFIX) had Business Combination, Contingent Consideration, Liability, Current of $4.29 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2026-02-24
- 2025-12-31: Business Combination, Contingent Consideration, Liability, Current $4.29M.
- 2024-12-31: Business Combination, Contingent Consideration, Liability, Current $7.10M.
- 2023-12-31: Business Combination, Contingent Consideration, Liability, Current $1.00M.
- 2022-12-31: Business Combination, Contingent Consideration, Liability, Current $1.00M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2025-12-31 | $4.29M 10-K · filed 2026-02-24 |
| 2024-12-31 | $7.10M 10-K · filed 2026-02-24 |
| 2023-12-31 | $1.00M 10-K · filed 2025-02-25 |
| 2022-12-31 | $1.00M 10-K · filed 2023-03-06 |
| 2021-12-31 | $17.20M 10-K · filed 2023-03-06 |
| 2020-12-31 | $14.90M 10-K · filed 2022-02-25 |
| 2019-12-31 | $14.70M 10-K · filed 2021-02-26 |
| 2018-12-31 | $13.60M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |